Yasuo Matsumura Selected Research

Metrorrhagia (Spotting)

2/2011	Endothelin ETB receptor is involved in sex differences in the development of balloon injury-induced neointimal formation.
12/2009	Inhibition of endothelin ETB receptor system aggravates neointimal hyperplasia after balloon injury of rat carotid artery.
4/2007	Involvement of the endothelin ET(B) receptor in gender differences in deoxycorticosterone acetate-salt-induced hypertension.
11/2004	Exaggerated vascular and renal pathology in endothelin-B-receptor-deficient rats with subtotal nephrectomy.
8/2004	Role of endothelin ETB receptor in the pathogenesis of monocrotaline-induced pulmonary hypertension in rats.
6/2004	Role of endothelin ETB receptor in partial ablation-induced chronic renal failure in rats.
10/2002	Role of endothelin B receptor in the pathogenesis of ischemic acute renal failure.
9/2002	Role of endothelin ET(B) receptors in the renal hemodynamic and excretory responses to big endothelin-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuo Matsumura Research Topics

Disease

48	Ischemia 01/2020 - 10/2002
38	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 03/2002
12	Hypertension (High Blood Pressure) 01/2020 - 05/2002
11	Hypoxia (Hypoxemia) 11/2013 - 10/2003
10	Necrosis 09/2013 - 08/2002
9	Ventricular Remodeling 11/2013 - 05/2005
8	Metrorrhagia (Spotting) 02/2011 - 09/2002
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 09/2007
7	Pulmonary Hypertension 01/2021 - 08/2004
7	Myocardial Ischemia (Ischemic Heart Diseases) 01/2019 - 01/2005
7	Fibrosis (Cirrhosis) 11/2013 - 10/2003
6	Reperfusion Injury 07/2013 - 08/2002
5	Wounds and Injuries (Trauma) 10/2012 - 06/2004
4	Vascular Diseases (Vascular Disease) 11/2014 - 04/2005
4	Heart Failure 09/2013 - 01/2005
4	Hypertrophy 01/2012 - 08/2004
3	Chronic Renal Insufficiency 01/2022 - 01/2009
3	Right Ventricular Hypertrophy 01/2021 - 06/2018
3	Inflammation (Inflammations) 09/2013 - 10/2003
3	Atherosclerosis 01/2012 - 10/2005
3	Chronic Kidney Failure (Chronic Renal Failure) 05/2008 - 06/2004
2	Hyperplasia 08/2019 - 12/2009
2	Fistula 08/2019 - 11/2009
2	Vascular Remodeling 01/2019 - 10/2012
2	Vascular System Injuries 11/2014 - 01/2013
2	Proteinuria 01/2014 - 05/2008
2	Neointima 02/2011 - 12/2009

Drug/Important Bio-Agent (IBA)

25	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2019 - 08/2003
24	Endothelin-1 (Endothelin 1)IBA 09/2013 - 08/2002
17	Endothelins (Endothelin)IBA 11/2014 - 09/2002
15	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 08/2002
14	Superoxides (Superoxide)IBA 08/2019 - 10/2005
9	SaltsIBA 01/2020 - 05/2002
8	Desoxycorticosterone Acetate (DOCA)FDA Link 01/2020 - 05/2002
8	Nitric Oxide Synthase (NO Synthase)IBA 01/2020 - 09/2003
8	AtrasentanIBA 07/2012 - 08/2004
7	Messenger RNA (mRNA)IBA 08/2019 - 08/2002
5	MonocrotalineIBA 01/2021 - 08/2004
5	Angiotensin Receptor AntagonistsIBA 11/2014 - 05/2005
5	AntioxidantsIBA 11/2013 - 03/2002
5	CytokinesIBA 06/2010 - 06/2006
5	A 192621IBA 12/2009 - 09/2002
4	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 08/2019 - 01/2010
4	Oxygen (Dioxygen)IBA 11/2013 - 02/2010
4	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 11/2013 - 01/2005
4	Proteins (Proteins, Gene)FDA Link 09/2011 - 09/2003
4	Carboxylic AcidsIBA 02/2011 - 08/2004
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2010 - 08/2002
4	NF-kappa B (NF-kB)IBA 12/2007 - 10/2003
4	Histidine (L-Histidine)FDA Link 11/2006 - 05/2002
4	CarnosineIBA 11/2006 - 05/2002
3	AgmatineIBA 01/2020 - 03/2008
3	Acetates (Acetic Acid Esters)FDA Link 01/2020 - 12/2006
3	Desoxycorticosterone (Deoxycorticosterone)IBA 01/2020 - 12/2006
3	Urea (Carbamide)FDA LinkGeneric 01/2020 - 05/2008
3	NADPH Oxidases (NAD(P)H oxidase)IBA 08/2019 - 12/2006
3	Malondialdehyde (Propanedial)IBA 01/2019 - 12/2011
3	Estrogens (Estrogen)FDA Link 11/2014 - 09/2012
3	tempolIBA 07/2013 - 12/2003
3	NADP (NADPH)IBA 09/2011 - 10/2005
3	Endothelin-Converting EnzymesIBA 05/2011 - 09/2008
3	flavangenolIBA 01/2011 - 09/2005
3	sesaminIBA 03/2008 - 09/2002
3	Nitric Oxide DonorsIBA 03/2006 - 11/2004
3	NG-Nitroarginine Methyl Ester (L-NAME)IBA 07/2005 - 11/2004
2	IndicanIBA 01/2022 - 01/2021
2	NitratesIBA 01/2021 - 01/2019
2	CreatinineIBA 01/2020 - 05/2008
2	NitrogenIBA 01/2020 - 05/2008
2	Thioctic Acid (Lipoic Acid)IBA 08/2019 - 03/2002
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2019 - 12/2011
2	2- amino- 4- ((3- (carboxymethyl)phenyl)(methyl)phosphono)butanoic acidIBA 01/2019 - 12/2011
2	Soluble Guanylyl CyclaseIBA 06/2018 - 01/2009
2	Hydralazine (Apresoline)FDA LinkGeneric 01/2014 - 12/2003
2	Celiprolol (ST1396)IBA 11/2013 - 05/2005
2	efaroxanIBA 10/2013 - 01/2009
2	moxonidine (Moxon)IBA 10/2013 - 01/2009
2	ImidazolinesIBA 10/2013 - 01/2009
2	Endothelin Receptors (Endothelin Receptor)IBA 09/2013 - 01/2012
2	Estrogen ReceptorsIBA 01/2013 - 05/2012
2	Pharmaceutical PreparationsIBA 01/2013 - 01/2009
2	Angiotensin IIIBA 01/2013 - 07/2009
2	candesartanIBA 07/2012 - 05/2005
2	Biological ProductsIBA 01/2012 - 10/2003
2	gamma-Aminobutyric Acid (GABA)IBA 09/2011 - 11/2009
2	GABA-B ReceptorsIBA 09/2011 - 11/2009
2	GABA-B Receptor AntagonistsIBA 09/2011 - 11/2009
2	benzocycloheptapyridineIBA 02/2011 - 12/2009
2	J 104132IBA 02/2011 - 12/2009
2	AcidsIBA 02/2011 - 12/2009
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2011 - 02/2010
2	Nifedipine (Adalat)FDA LinkGeneric 01/2011 - 02/2010
2	Transforming Growth Factor beta (TGF-beta)IBA 06/2010 - 11/2009
2	olmesartanIBA 02/2010 - 12/2007
2	Matrix Metalloproteinases (MMPs)IBA 02/2010 - 12/2007
2	salicylhydroxamic acid (SHAM)IBA 11/2009 - 11/2007
2	Capsaicin (Zostrix)FDA Link 04/2009 - 05/2008

Therapy/Procedure

21	Nephrectomy 01/2014 - 08/2003
5	Therapeutics 11/2014 - 12/2003
4	Intravenous Injections 01/2020 - 11/2009